During our October federal advocacy drop-in session, we learned about several pieces of legislation that had a good chance to pass before the end of
By CAC2 Individual Member Jennifer Flowers Rhabdomyosarcoma became a common word in my family when I was three years old. By the time of diagnosis,
In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) held a one-hour Conversations on Cancer public panel discussion on
By CAC2 Student Member Joshua Omale Attending the 2024 International Cancer Week, organized by Nigeria’s National Institute for Cancer Research and Treatment (NICRAT), was indeed
The October 10 Federal Advocacy drop-in session covered three pieces of authorizing legislation and provided an update on possible appropriations for FY2025. Each of the
By CAC2 Member Autumn Gentry, MACC Fund This collaborative state advocacy effort was due to the dedicated work of a pair of CAC2 members in
At CAC2 we love to celebrate when our members work together. We offer congratulations to Supporting Organization Day One Biopharmaceuticals and CAC2 member authors and
The NCI Council of Research Advocates met virtually on June 26 and heard the latest legislative report, with updates on appropriations, cancer-related legislation, and other
By CAC2 Student Member Joshua Omale In the heart of advocacy, the rhythm of change reverberates most profoundly at the grassroots level. For me, this
By CAC2 Member Steven Giallourakis (The Steven G. Cancer Foundation) When someone has succeeded in life, we tend to think of them as successful. That
